Guardian Pharmacy Services (NYSE:GRDN) Trading Down 5.9% – Here’s What Happened

Guardian Pharmacy Services, Inc. (NYSE:GRDN) fell 5.9% on Friday . The stock traded as low as $23.64 and last traded at $23.68. 66,701 shares traded hands during trading, a decline of 57% from the average session volume of 156,321 shares. The stock had previously closed at $25.17.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on GRDN shares. Raymond James began coverage on shares of Guardian Pharmacy Services in a report on Monday, October 21st. They issued an “outperform” rating and a $21.00 price objective for the company. Truist Financial raised their price target on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, November 15th. Finally, Stephens began coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 price objective on the stock.

Guardian Pharmacy Services Trading Down 6.4 %

The stock’s 50 day simple moving average is $20.63.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing the consensus estimate of $0.19 by ($2.19). The firm had revenue of $314.39 million during the quarter, compared to analysts’ expectations of $303.21 million. As a group, equities analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Steven D. Cosler bought 7,000 shares of the stock in a transaction dated Tuesday, November 19th. The stock was bought at an average price of $21.22 per share, for a total transaction of $148,540.00. Following the completion of the acquisition, the director now directly owns 17,713 shares in the company, valued at approximately $375,869.86. This trade represents a 65.34 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Thomas J. Salentine, Jr. acquired 35,714 shares of Guardian Pharmacy Services stock in a transaction on Friday, September 27th. The stock was purchased at an average cost of $14.00 per share, with a total value of $499,996.00. Following the completion of the transaction, the director now directly owns 35,714 shares in the company, valued at $499,996. This represents a ∞ increase in their position. The disclosure for this purchase can be found here.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Franklin Resources Inc. purchased a new stake in Guardian Pharmacy Services in the third quarter worth $8,575,000. Wellington Management Group LLP purchased a new position in shares of Guardian Pharmacy Services during the 3rd quarter valued at $8,400,000. Allspring Global Investments Holdings LLC bought a new position in shares of Guardian Pharmacy Services during the 3rd quarter worth $5,460,000. Maven Securities LTD purchased a new stake in Guardian Pharmacy Services in the 3rd quarter worth about $3,033,000. Finally, Seven Grand Managers LLC bought a new stake in Guardian Pharmacy Services in the 3rd quarter valued at about $2,515,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.